US 12043640
Prodrugs of STAT3 inhibitors
granted A61PA61P35/00
Quick answer
US patent 12043640 (Prodrugs of STAT3 inhibitors) held by Tvardi Therapeutics, Inc. expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tvardi Therapeutics, Inc.
- Grant date
- Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P35/00